COYA
Coya Therapeutics Inc
Clinical-stage biotechnology company developing proprietary therapies to enhance the function of regulatory T cells (Tregs) for treatment of neurodegenerative, autoimmune, and metabolic diseases
CUSIP: 22407B108HealthcareUS1 holder
Total Value
$9.44M
Total Shares
1.27M
Net Share Change
+806.0K
Activity
1 buying
Investor
Value
Shares
Weight
Change
Greenlight Capital
$9.44M1.27M shares
ADD+806.0K(+172.2%)